These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8237297)

  • 1. Monoamine oxidase inhibitors and anesthesia: an updated literature review.
    Blom-Peters L; Lamy M
    Acta Anaesthesiol Belg; 1993; 44(2):57-60. PubMed ID: 8237297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible inhibitor of MAO-A(RIMA)].
    Inoue T; Koyama T
    Nihon Rinsho; 2001 Aug; 59(8):1530-4. PubMed ID: 11519153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G; Finberg JP; Youdim MB
    Clin Neuropharmacol; 1993; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors: reversible and irreversible.
    Rudorfer MV
    Psychopharmacol Bull; 1992; 28(1):45-57. PubMed ID: 1609042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
    Lotufo-Neto F; Trivedi M; Thase ME
    Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaesthesia and the new generation monoamine oxidase inhibitors.
    McFarlane HJ
    Anaesthesia; 1994 Jul; 49(7):597-9. PubMed ID: 8042725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors: pharmacology and implications in the perioperative period.
    Skoog RE
    J Post Anesth Nurs; 1989 Aug; 4(4):264-7. PubMed ID: 2474652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAOIs to RIMAs in anaesthesia--a literature review.
    Hill S; Yau K; Whitwam J
    Psychopharmacology (Berl); 1992; 106 Suppl():S43-5. PubMed ID: 1546140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide: a reversible inhibitor of monoamine oxidase type A.
    Baldwin D; Rudge S
    Br J Hosp Med; 1993 Apr 7-20; 49(7):497-9. PubMed ID: 8490690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible monoamine oxidase-A inhibitors in panic disorder.
    Bakish D; Saxena BM; Bowen R; D'Souza J
    Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of monoamine oxidase inhibitors.
    Mallinger AG; Smith E
    Psychopharmacol Bull; 1991; 27(4):493-502. PubMed ID: 1813896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.